David Mametja

480 total citations
9 papers, 264 citations indexed

About

David Mametja is a scholar working on Epidemiology, Infectious Diseases and Economics and Econometrics. According to data from OpenAlex, David Mametja has authored 9 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Infectious Diseases and 2 papers in Economics and Econometrics. Recurrent topics in David Mametja's work include Tuberculosis Research and Epidemiology (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Pneumonia and Respiratory Infections (3 papers). David Mametja is often cited by papers focused on Tuberculosis Research and Epidemiology (5 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Pneumonia and Respiratory Infections (3 papers). David Mametja collaborates with scholars based in South Africa, United States and Papua New Guinea. David Mametja's co-authors include Nazir Ismail, Yogan Pillay, Nonkqubela Bantubani, Norbert Ndjeka, Graeme Meintjes, Alane Izu, Gary Maartens, Ebrahim Variava, Jennifer Hughes and Xavier Padanilam and has published in prestigious journals such as American Journal of Clinical Nutrition, The Lancet Infectious Diseases and AIDS.

In The Last Decade

David Mametja

9 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Mametja South Africa 6 216 166 66 31 20 9 264
Michael P. Chen United States 7 209 1.0× 161 1.0× 76 1.2× 17 0.5× 33 1.6× 10 261
Renia Coghlan Switzerland 5 254 1.2× 189 1.1× 116 1.8× 15 0.5× 14 0.7× 7 310
Sujit Suchindran United States 8 239 1.1× 214 1.3× 84 1.3× 14 0.5× 56 2.8× 19 385
Elizabeth Gardiner United States 6 403 1.9× 299 1.8× 149 2.3× 29 0.9× 19 0.9× 6 453
Emily J. Hecker United States 8 210 1.0× 216 1.3× 92 1.4× 10 0.3× 33 1.6× 17 338
Yasmeen Hanifa United Kingdom 12 289 1.3× 229 1.4× 116 1.8× 24 0.8× 18 0.9× 17 395
Geisa Fregona Brazil 13 325 1.5× 229 1.4× 86 1.3× 14 0.5× 55 2.8× 27 392
Nimalan Arinaminpathy United Kingdom 10 277 1.3× 171 1.0× 45 0.7× 37 1.2× 30 1.5× 23 376
Epifanio Sánchez United States 5 407 1.9× 325 2.0× 156 2.4× 29 0.9× 19 0.9× 5 474
T A Kenyon Botswana 7 258 1.2× 239 1.4× 110 1.7× 28 0.9× 25 1.3× 8 330

Countries citing papers authored by David Mametja

Since Specialization
Citations

This map shows the geographic impact of David Mametja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Mametja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Mametja more than expected).

Fields of papers citing papers by David Mametja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Mametja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Mametja. The network helps show where David Mametja may publish in the future.

Co-authorship network of co-authors of David Mametja

This figure shows the co-authorship network connecting the top 25 collaborators of David Mametja. A scholar is included among the top collaborators of David Mametja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Mametja. David Mametja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Moyo, Sizulu, Farzana Ismail, Martie van der Walt, et al.. (2022). Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017–19: a multistage, cluster-based, cross-sectional survey. The Lancet Infectious Diseases. 22(8). 1172–1180. 65 indexed citations
2.
Broughton, Edward, Lindiwe Mvusi, Norbert Ndjeka, et al.. (2020). Examining the cost of community-based tuberculosis treatment in South Africa. The International Journal of Tuberculosis and Lung Disease. 24(6). 612–618. 2 indexed citations
3.
Ndjeka, Norbert, Francesca Conradie, Kathryn Schnippel, et al.. (2015). Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis. The International Journal of Tuberculosis and Lung Disease. 19(8). 979–985. 101 indexed citations
4.
Izu, Alane, Nazir Ismail, Chikwe Ihekweazu, et al.. (2015). Nationwide and regional incidence of microbiologically confirmed pulmonary tuberculosis in South Africa, 2004–12: a time series analysis. The Lancet Infectious Diseases. 15(9). 1066–1076. 59 indexed citations
5.
Page‐Shipp, Liesl, Wendy Stevens, David A. Clark, et al.. (2014). Successes, challenges and lessons from a novel deployment of Xpert<SUP>®</SUP> MTB/RIF at a major South African public event [Short Communication]. The International Journal of Tuberculosis and Lung Disease. 18(4). 438–440. 4 indexed citations
6.
Bristow, Claire, Laura Jean Podewils, Liza Bronner Murrison, et al.. (2013). TB tracer teams in South Africa: knowledge, practices and challenges of tracing TB patients to improve adherence. BMC Public Health. 13(1). 801–801. 9 indexed citations
7.
Churchyard, Gavin, et al.. (2007). Business and AIDS: sectoral challenges and opportunities. AIDS. 21(Suppl 3). S85–S89. 15 indexed citations
8.
Jinabhai, C C, et al.. (1997). Development of a health programme in a peri-urban informal settlement in Besters, KwaZulu-Natal.. PubMed. 87(6). 741–6. 2 indexed citations
9.
Mametja, David, et al.. (1993). Vitamin A deficiency among children in a periurban South African settlement. American Journal of Clinical Nutrition. 57(6). 904–907. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026